Newsbenzinga
Kyverna Therapeutics Therapy Delivers Sustained Relief in Rare Neurological Conditions
· Published
Article summary
Kyverna Therapeutics reports positive one-year clinical trial data for miv-cel in stiff person syndrome and myasthenia gravis.
An excerpt from the original article.
Comments —
Loading comments…